ABSTRACT
Testosterone therapy can improve quality of life in aging men because aging is accompanied by declining testosterone levels that may contribute to decreases in muscle mass, bone density, libido, stamina, and cognition. Hypogonadal men can be identified by a test for bioavailable testosterone or by a free testosterone assay that uses dialysis or ultracentrifugation methods.
Footnotes
↵* The author has indicated that he has relationship swhich, in the context of his presentation, could be perceived as potential conflict to finterest. He has received grants or research support from Merck, Nestec, Bayer, and B. Braun McGaw, and has served on the speaker’s bureau for LXN, Organon, GeriMed of America, UniMed, Essentia, Alza, Pharmacia & Upjohn, Glaxo Wellcome, B. Braun McGaw, Bristol-Myers Squibb, Hoechst Marion Roussel, Merck, Novartis, Parke-Davis, Smithkline Beecham, and Pfizer.
- Copyright © 2000 The Cleveland Clinic Foundation. All Rights Reserved.
Jump to section
Related Articles
Cited By...
- No citing articles found.